trastuzumab,neratinib
roche,knight therapeutics,pierre fabre,puma
['summit', 'neratinib', 'puma', 'pbyi', 'biotec']
$pbyi [15s. delayed]: issued press release on june 04, 09:05:00: puma biotechnology presents final results from the biliary tract cohort of the phase 2 summit basket trial of neratinib at the asco 2022 annual meeting 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time